Hospitalized COVID-19 patients are substantially more likely to harbor autoantibodies –antibodies directed at their own tissues or at substances their immune cells secrete into the blood — than people without COVID-19, according to a new study.
Hospitalized COVID-19 patients are substantially more likely to harbor autoantibodies –antibodies directed at their own tissues or at substances their immune cells secrete into the blood — than people without COVID-19, according to a new study.